Home Archive
Archive
2022 Volume 43 Issue 10  Published: 2022-10-10
    Topic
  • Hong CHEN , Zhuhui ZHAO , Guomei SHEN , Lijun ZHOU , Xiaowen ZHAI
    doi: 10.13683/j.wph.2022.10.001

    A hospital designed a medication log based on the guiding principles of clinical application of antibiotics. The items filled in the log included symptoms, signs and examination results of children, so as to comprehensively reflect the basis of doctors' prescriptions. Taking into account the non-medical factors affecting doctors' prescriptions, the reasons for prescribing were added in the log, such as the need for illness, the experience of medication, and the request of family members. The logs were filled in by physicians independently, and the results were counted regularly by specially-assigned personnel, and the medication situation was summarized and analyzed at the regular meeting of the department, and rectification suggestions were put forward. After the using the log, the hospital obtained the data of irrational drug use for different reasons in pediatric outpatient department for the first time, which clarified the direction of improvement. Doctors' awareness of rational drug use was improved and their self-discipline was strengthened. Medication management efficiency improved. In the future, the hospital will continue to implement medication log and promote it to other outpatient departments, accelerate the construction of electronic medical records, embed the electronic log into the doctor's workstation, and optimize medication assessment.

  • Topic
  • Guomei SHEN , Xuan GAO , Lijun ZHOU , Jie XU , Hui XU , Junhua TIAN , Xiaowen ZHAI
    doi: 10.13683/j.wph.2022.10.002

    At present, the irrational use of antimicrobial agents and the drug-resistance of bacteria are severe problems in the world. Based on the successful cases of scientific antimicrobial stewardship (AMS) in children's hospital of Fudan university, we continued to collect the key problems in promoting the rational use of antimicrobial agents and sort out the reasons of unreasonable use. This study aimed to carry out relevant research on the implementation of personalized intervention measures in the terms of parents' awareness of antibiotic usage, investigation and analysis of doctors' prescription behavior, strengthening the performance management of doctors and keeping a log of the records of usage of antimicrobial agents in four members of Fudan Pediatric Medical Alliance, and to encourage all medical alliances to explore and establish scientific AMS suitable for themselves.

  • Topic
  • Silei YAN , Xiaoyan DONG
    doi: 10.13683/j.wph.2022.10.003

    Lower respiratory tract infection is the most common infectious disease in children, its pathogenic microorganisms mainly include bacteria, viruses, mycoplasma, chlamydia, Mycobacterium tuberculosis and so on. In recent years, the widespread use of antibiotics, made the drug-resistant bacteria constantly emerging, which brings great challenges to clinical anti-infection treatment. This present article reviewed the drug resistance of pathogens in children with lower respiratory tract infection, in order to provide reference or inspiration for clinicians to treat children lower respiratory tract infection.

  • Topic
  • Gang YU , Hailin ZHANG
    doi: 10.13683/j.wph.2022.10.004

    Lower respiratory tract infections in children are the leading cause of hospitalization in children and the leading cause of children's death worldwide. The pathogen spectrum of lower respiratory tract infections includes viruses, bacteria, mycoplasma pneumoniae, fungi and so on. Coinfections are common. The younger, the sicker, or the host with immunodeficiency, the greater the risk of coinfections. Children with coinfections are more difficult to treat and may have a worse prognosis than those with Single-pathogen infection. Pediatricians should pay attention to the combined application of antibacterials in children with lower respiratory tract coinfection.

  • Topic
  • Weijian ZHANG , Hanmin LIU
    doi: 10.13683/j.wph.2022.10.005

    Respiratory diseases are the most common diseases in childhood. Macrolides, which are often used as antibiotics, show immunomodulatory effects in clinical use and have certain effect on childhood respiratory diseases, with uncertain mechanism. This review focuses on immunomodulatory effects of macrolides on the prognosis of childhood respiratory diseases.

  • Topic
  • Qianqian FU , Yuanyuan QI , Xiaobo ZHANG
    doi: 10.13683/j.wph.2022.10.006

    Children are the particular group during clinical treatments, with rapid and immature physical development and largely individual differences. In recent years, unreasonable usage of antibacterial drugs for children is a serious problem. The antimicrobials pharmacokinetic/pharmacodynamic (PK/PD) model and its parameters can provide evidence for antimicrobial use in children, which benefits for rational use of antibiotics in children and optimizies the clinical individualized drug delivery schemes.

  • Topic
  • Jinyan TANG , Ruixin WANG , xuanxuan YAN , Yiqing WANG , Xiaohua YING
    doi: 10.13683/j.wph.2022.10.007

    Cost-effectiveness threshold (CET) can judge the economy efficiency of different medical intervention measures. It is an important reference standard for medical insurance directory access. It is also an important pharmacoeconomic evidence for the lack of medical insurance access negotiations for innovative drugs in China. This paper summarizes the experience of the application of CET in the world and lays a foundation for the determination and application of innovative drug CET in China. CET is an important basis for the selection of health interventions in many countries. It is mainly divided into implicit threshold and explicit threshold, most countries use implicit threshold for decision-making. The per capita GDP multiple is the CET mode selected by most countries. In the face of different application scenarios of innovative drugs, such as rare diseases treatment, end-stage treatment and disease treatment of different severity, countries make adjustments to different degrees on the basis of general CET. It is not clear whether CET is used in China's health decision-making. It is suggested to explore the threshold and level in line with China's national conditions on the basis of international experience, focus on exploring the application of hidden threshold in medical insurance access and preferential policies for rare diseases and end-of-life drugs and actively promote the scientific determination of CET in China.

  • Topic
  • Ruoting WANG , Jianfeng LI , Jingyi ZHANG , Guowei LI
    doi: 10.13683/j.wph.2022.10.008

    Randomized controlled trials (RCT) of direct comparisons are the gold standard for assessing comparative treatment effects between different interventions. When it is not feasible to conduct a direct comparative RCT due to ethical and economic reasons, the published clinical research evidence and available data can be used to indirectly compare different interventions. However, the commonly used indirect comparison methods deal with the effectineness and safety the efficacy of different interventions separately, potentially leading to difficulty in decision-making caused by the inconsistency between the effectivencess and safety. The number needed to treat for net effect (NNTnet), as a novel indirect comparison method can synthetically assess the comparative treatment effects of different interventions by combining their efficacy and safety simultaneously. The NNTnet can provide important referance and evidence support for health professionals, researchers and resource managers to make scientific decisions in clinical practice.

  • Topic
  • Yitian LANG , Xiaoyan LIU , Bin WU
    doi: 10.13683/j.wph.2022.10.009
    Objectives

    Due to the unique mechanism of immunotherapy, the shape of its survival curve differs from that of conventional treatment. In order to better understand the causes of this type of survival curve and how to optimize the long-term simulation survival curves of immunotherapy, this study provides an introduction and an example demonstration to serve as a reference for relevant researchers.

    Method

    Taking the survival data of Checkmate-067 trial as an example, different survival models are used to extrapolate the survival data based on 0 to 27 months, and the results of extrapolated curve are compared with the actual survival curve of 28 to 60 months.

    Results

    In this example, the shape of overall survival curve is consistent with the conventional shape, and it is well fitted with different survival models, but the shape of progression free survival (PFS) curve with immunotherapy is significantly different from that with conventional therapy, and the fit is poor.

    Conclusion

    For the long-term survival simulation of immunotherapy, it is not recommended to select the model only considering the Akaike information criteria and Bayesian information criteria. Moreover, it is necessary to optimize the model based on the characteristics of immunotherapy, and making the corresponding fitting curve as far as possible for visual inspection. Also, the curve fitting requires special optimization or selection of a more flexible survival model when encountering the pseudo-progression or plateau.

  • Topic
  • Qingqiang LEI , Zixuan HE , Min HU , Wen CHEN
    doi: 10.13683/j.wph.2022.10.010

    Indication expansion is a common situation we ofter face in the dynamic adjustment of the national medical insurance drug list in China. This study reviewed the experiences of drug price adjustment in typical countries under the condition of indication expansion and summarized the enlightenment to China. Typical countries took variable measures to determine the drug prices after the expansion of new indications such as access after evaluations by indications based on list prices, weighted pricing method based on value and sales, volume-price drug pricing, indication-based pricing based on risk sharing agreements, and drug pricing based on evaluations in the initial access process. Different approaches have different impacts on protecting the financial risk of the medical insurance funds, encouraging research and development and innovation in the pharmaceutical industry, and ensuring the drug accessibility for the insured patients with new indications. We should clarify the main problems and challenges of medical insurance management in the current stage in China, draw on useful experiences, and improve the price adjustment strategies of medical insurance drugs in the case of indication expansion.

  • Topic
  • Kaixuan WANG , Shunping LI , Lei DOU , Shixian LIU , Zhao SHI , Ruixue WANG , Xiaohong ZHU , Zehua SONG
    doi: 10.13683/j.wph.2022.10.011
    Objective

    To construct a normative evaluation index system for the application of health state utility value in pharmacoeconomic evaluation model, in order to facilitate peer review, and standardize the application of health state utility value, thereby improving the quality of pharmacoeconomic evaluation.

    Methods

    The initial indicators were determined based on literature analysis, group discussion and expert interviews. Delphi method was applied to construct the evaluation index system.

    Results

    The expert positive coefficient in both rounds was 1, the authority coefficient mean was 0.89, and the coordination coefficient was statistically significant (P<0.001). According to the importance scores and experts' modifications comments, an evaluation index system was formed, which consisted of 5 primary indicators, including source reports, literature citations, measurement population, measurement tools/methods, and numerical adjustments, and 16 secondary indicators.

    Conclusion

    The evaluation index system is scientific and reliable, which can be used to evaluate the health state utility values in pharmacoeconomic evaluation model.

  • Article
  • Ziru XU , Mingyu MAO , Yu ZHANG , Jinnuo ZHU , Qingqing XIONG , Ningjing HUANG
    doi: 10.13683/j.wph.2022.10.012
    Objective

    To investigate the clinical effect of Zhichan decoction on Parkinson's disease (PD) with liver and kidney deficiency and its effect on intestinal flora.

    Methods

    72 PD patients with liver and kidney deficiency were included in the study. A randomized, double-blind, placebo-controlled clinical design was adopted. There were 36 cases in the treatment group and 36 cases in the control group. Both groups were routinely given western medicine, the treatment group was given Zhichan decoction granules, and the control group was given Zhichan decoction placebo. The course of treatment was 12 weeks. The scores of unified PD rating scale (UPDRS) and the changes of intestinal flora were observed.

    Results

    After 12 weeks of treatment, the UPDRS scores in the treatment group was lower than the control group (P<0.05). There was no significant difference in the abundance of Prevotella, Blautia, Faecalibacterium and Bacteroides between the two groups after 12 weeks of treatment, while the abundance of Blautia in the treatment group showed an increasing trend. The abundance of Haemophilus in the treatment group increased and was significantly different from that before treatment (P<0.05), while showed a downward trend in the control group. After treatment, the abundance of Akkermansia reduced in the treatment group and increased in the control group. The abundance of Porphyromonas reduced in the treatment group, while significantly increased in the control group after treatment (P<0.05).

    Conclusion

    Zhichan decoction granule can improve the clinical symptoms of PD, and can significantly increase the abundance level of Haemophilus, reduce the abundance level of Akkermansia and Porphyromonas.

  • Article
  • Baojie DONG , Bo LIU , Peifen YUE
    doi: 10.13683/j.wph.2022.10.013
    Objective

    To explore the effect of Yueshi Yigan Hewei decoction on gastrointestinal dynamics and serum kaliikrein (KLK) 5 and pepsinogen (PG) levels in patients with gastroesophageal reflux disease (GERD).

    Methods

    A total of 120 patients with hepatogastric discordant GERD admitted to the department of medicine, Dongzhimen Hospital, Beijing University of Chinese Medicine from April 2018 to January 2020 were taken as the research objects. The patients were randomly divided into the observation group and the control group according to the random number table method, with 60 cases each group. The observation group was treated with Yueshi Yigan Hewei decoction, and the control group was treated with rabeprazole sodium enteric-coated tablets. After two courses of treatment, the clinical curative effect, the scores of traditional Chinese medicine (TCM) syndromes, the levels of serum motilin (MTL), gastrin (GAS), KLK5 and PG, and the adverse reactions of the two groups were compared before and after treatment.

    Results

    After treatment, the clinical effective rate of the observation group was higher than that of the control group (93.34% vs 81.67%), the difference was statistically significant (P<0.05). After treatment, the TCM syndromes of acid regurgitation, heartburn, belching and retrosternal pain score in the two groups were improved, and the improvement in the observation group were better than those in the control group (P<0.05). After treatment, the average score of TCM syndromes in the observation group was lower than that in the control group, with a statistically significant difference (Z=-2.096, P=0.037), the difference was statistically significan (P<0.05). After treatment, the level of MTL in the observation group was significantly higher than that in the control group, while the level of GAS was significantly lower than that in the control group (P<0.05). After treatment, the level of serum KLK5 in the observation group was significantly lower than that in the control group, the level of PG in the observation group was significantly higher than that in the control group (P<0.05). The incidence of adverse reactions in the observation group was 3.33%, which was lower than 15.00% in the control group (P<0.05).

    Conclusion

    Yueshi Yigan Hewei Decoction has a more significant effect in treating GERD. It is safe and effective.

  • Article
  • Da GAO , Yanliang YANG , Yu WANG , Wenjun XU
    doi: 10.13683/j.wph.2022.10.014
    Objective

    To analyze the clinical efficacy of Kangfuxin liquid combined with Xiangsha Yangwei pill in treating chronic atrophic gastritis (CAG) with spleen deficiency and qi stagnation syndrome.

    Methods

    80 patients with CAG spleen deficiency and qi stagnation syndrome were selected from Electric Power Teaching Hospital of Capital Medical University from April 2019 to October 2021 and randomly divided into group A (40 patients treated with conventional western medicine+Kangfuxin liquid) and group B (40 patients treated with Xiangsha Yangwei pill on the basis of group A). The course of treatment was 8 weeks.. The gastric mucosa, serum gastrin 17 (G-17), serum interleukin-6 (IL-6), calcitonin gene related peptide (CGRP) and tumor necrosis factor-α(TNF-α) levels of the two groups were observed before and after treatment.

    Results

    The total effective rate of group B was better than that of group A, with a statistically significant difference (P<0.05). After treatment, the total score of traditional Chinese medicine symptoms, gastric mucosa score, serum IL-6 and TNF-α levels in group B were significantly improved compared with group A (P<0.05). After treatment, the levels of serum G-17 and CGRP in group B were significantly higher than those in group A, and the differences were statistically significant (P<0.05).

    Conclusion

    Kangfuxin liquid combined with Xiangsha Yangwei pill has a definite effect on patients with CAG spleen deficiency and qi stagnation syndrome. It can effectively regulate the levels of gastrointestinal hormones and inflammatory factors, significantly reduce the total score of traditional Chinese medicine symptoms, and effectively improve the condition of gastric mucosa.

  • Article
  • Xiao CHANG , Fang WANG , Fang SUN
    doi: 10.13683/j.wph.2022.10.015
    Objective

    To investigate the effects of Ruanjian Qingmai granules on serum vascular endothelial growth factor (VEGF). Growth differentiation factor (GDF)-15 and carotid plaque vulnerability in patients with acute coronary syndrome (ACS).

    Methods

    A total of 123 ACS patients admitted to the department of cardiology, Qingdao municipal hospital from January 2019 to January 2021 were selected and randomly divided into observation group (n=62) and control group (n=62) by random number table method. The control group was given atorvastatin, while the observation group was given atorvastatin and Ruanjian Qingmai granules. The clinical efficacy, serum VEGF, GDF-15, carotid plaque vulnerability, brain natriuretic peptide (BNP) and left ventricular ejection fraction (LVEF), cardiovascular adverse events and drug safety were compared between the two groups.

    Results

    The total effective rate of the observation group was higher than that of the control group (90.32% vs 72.13%, P<0.05). After treatment, the levels of serum GDF-15 and carotid plaque vulnerability in the two groups decreased with time, and the observation group were lower than those in the control group (P<0.05). Serum VEGF levels were increased with time, and the observation group was higher than that in the control group (P<0.05). After treatment, the serum BNP levels of the two groups decreased with time, and the observation group was lower than that of the control group (P<0.05). LVEF level increased with time, and the observation group was higher than that in the control group (P<0.05). The incidence of adverse cardiovascular events in the observation group was lower than that in the control group, and the difference was statistically significant (P<0.05).

    Conclusion

    The effect of Ruanjian Qingmai granules on ACS patients is significant, which may be related to the effective improvement of serum VEGF, GDF-15 and carotid plaque vulnerability.

  • Article
  • Song ZHONG , Qi CHANG , Nannan ZHOU
    doi: 10.13683/j.wph.2022.10.016
    Objective

    To investigate the effects of Bushen Baotai Zhuyun decoction combined with dydrogesterone in the treatment of fetal agitation (FA) of kidney deficiency type and its influence on endometrial receptivity.

    Methods

    From January 2019 to January 2020, 83 patients with FA of kidney deficiency type treated in Deyu medical Maanshan general hospital were selected and divided into the observation group (n=42) and the control group (n=41) by random number table method. The control group was given dydrogesterone, and the observation group was additionally given Bushen Baotai Zhuyun decoction on the basis of the treatment of the control group. The clinical efficacy, number and maturity of pinocytosis, peak systolic velocity (PSV), pulse index (PI) and resistance index (RI) of uterine artery, progesterone levels, improvement of clinical symptoms, and pregnancy outcomes were compared between the two groups.

    Results

    The total effective rate of observation group and control group were 92.86% and 73.17% respectively, and the difference was statistically significant (P<0.05). The number and maturity of pinocytosis in the two groups were significantly improved, and the improvement degree in the observation group was better than that in the control group, and the difference was statistically significant (P<0.05). The PSV, PI and RI of the two groups were significantly decreased, and these indicators of the observation group were lower than those of the control group, and the progesterone was significantly increased, and the progest erone of the observation group was higher than that of the control group, the differences were statistically significant (P<0.05). The improvement time of clinical signs in the observation group was lower than that in the control group, and the difference was statistically significant (P<0.05). The full-term pregnancy in the observation group was significantly higher than that in the control group, and the incidence of abortion was significantly lower than that in the control group, and the differences were statistically significant (P<0.05).

    Conclusion

    Bushen Baotai Zhuyun decoction combined with dydrogesterone is effective in the treatment of FA with deficiency of the kidney, which can effectively improve the level of endometrial receptivity.

  • Article
  • Jianhua MENG , Guomei SHEN , Lijun ZHOU , Jiali WANG , Zhang ZHOU , Xiaowen ZHAI
    doi: 10.13683/j.wph.2022.10.017
    Objective

    To compare and analyze the treatment of children with emergency and severe diseases in pediatric fever clinics before and after the outbreak of corona virus disease 2019 (COVID-19), and to explore the effectiveness and feasibility of the management model in pediatric fever clinics.

    Methods

    The clinical data of children with emergency and severe diseases in the fever clinic of children's hospital of Fudan university were collected from the pre-outbreak group (from December 1, 2021 to February 28, 2022) and the post-outbreak group (from March 1, 2022 to May 31, 2022). The effectiveness and feasibility of the management model were evaluated by evaluating the differences in treatment efficacy. Describe the setting and management of fever clinic: ①Double pre-examination triage. ②The implementation of pre-diagnosis examination. ③Equipped with perfect functional areas (rescue unit, observation unit, etc.). ④Medical and nursing facilities. ⑤Closed-loop management between doctors and patients. ⑥Multi-department consultation and collaboration. ⑦Personnel training and simulation exercises.

    Results

    A total of 49 860 and 7 784 children were diagnosed in the pre-epidemic group and post-epidemic group, respectively. A total of 38 COVID-19 positive cases were detected, 0 in the pre-epidemic group and 38 in the post-epidemic group. The severity of illness in the latter group was higher than that in the former group [early warning score: (0.29±0.64) vs (0.49±0.98), P<0.05], and convulsion, sepsis and severe pneumonia accounted for the highest proportion. The retention time of the latter group was longer than that of the former group [(202.2±42.9) min vs (118.2±25.6)min, P<0.05], and the main links were prolonged in nucleic acid detection time and referral time. There were 1 977 cases (95.5%) and 495 cases (85.9%) in the pre-epidemic and post-epidemic groups, and 94 cases (4.5%) and 81 cases (14.1%) in the pediatric intensive care unit (PICU), respectively. The difference was statistically significant (P<0.05). Among them, 89 cases (4.3%) and 80 cases (13.9%) were transferred to intensive observation, and 5 cases (0.24%) and 1 case (0.17%) were admitted to PICU.

    Conclusion

    Through the implementation of a reasonable preview triage, before clinical test, shortening the time of nucleic acids were facilities, fully equipped with the critical patients rescue units and personnel and critically ill children with a series of measures such as safety transportation, during an outbreak of pediatrics fever clinics closed loop management practical and effective, not only act as an alarm, can also identify and treat children with critical patients in time, ensure medical safety.

  • Article
  • Keliang LI , Lipeng ZHAO , Xiaoping WANG
    doi: 10.13683/j.wph.2022.10.018
    Objective

    To investigate the correlation between glycosylated hemoglobin and symptomatic intracerebral hemorrhage after intravenous thrombolysis with recombinant tissue plasminogen activator (rt-PA) in patients with acute ischemic stroke.

    Methods

    The clinical data of 367 patients with acute ischemic stroke who received intravenous thrombolytic therapy with rt-PA in Tongren Hospital, Shanghai Jiao Tong University School of Medicine from January 2018 to September 2021 were retrospectively analyzed. Logistic regression was used to analyze the relevant factors of symptomatic intracerebral hemorrhage after thrombolytic treatment in terms of gender, age, smoking history, thrombolytic time window, NIHSS score before treatment, history of hypertension, history of atrial fibrillation, history of diabetes, glycosylated hemoglobin, blood glucose and blood pressure value.

    Results

    Among 367 patients with acute ischemic stroke, 40 patients occurred symptomatic cerebral hemorrhage within 7 days after intravenous thrombolytic therapy. Logistic regression analysis showed that glycated hemoglobin level and NIHSS score before thrombolysis were independent risk factors for symptomatic cerebral hemorrhage within 7 days after thrombolysis [odds ratio (OR)=1.218, 95% confidence interval (CI):1.017 - 1.460, P=0.033; OR=1.128, 95%CI: 1.073 - 1.187, P<0.001].

    Conclusion

    The glycosylated hemoglobin level can be used as a predictor of symptomatic intracerebral hemorrhage after intravenous thrombolytic therapy with rt-PA. Higher glycosylated hemoglobin level predicts higher incidence of symptomatic intracerebral hemorrhage.

  • Article
  • Qin SHI , Yi SHI , Feng XU , Xuelian YANG
    doi: 10.13683/j.wph.2022.10.019
    Objective

    To investigate the effect of Shuxuetong on the changes of thrombelastogram (TEG) parameters in patients with acute ischemic stroke.

    Methods

    Retrospective analysis method was used to extract the case data of acute ischemic stroke patients hospitalized in the department of neurology of our hospital from January 2017 to December 2020. According to the conditions, 441 patients treated with western medicine alone were selected as the control group, and 465 patients treated with western medicine combined with Shuxuetong were selected as the observation group. The general clinical data were analyzed to observe the changes of indexes before and after TEG treatment. The differences of TEG parameters between the two groups were compared.

    Results

    According to the hierarchical analysis of the severity of the disease, there was no significant difference in TEG parameters between the two groups at admission, whether it was mild stroke or moderate to severe stroke (P>0.05). After 14 days of treatment, compared with the control group, R and K in the observation group were higher and Angle were lower than those in the control group after treatment in mild stroke patients (P<0.05), which had the same results in the moderate and severe stroke group. Before and after treatment, the R and K value and LY30% were increased in both the observation group and the control group in all stroke patients (P<0.05). Finally, the difference between the observation group and the control group before and after treatment was compared. It was found that the difference between the R and K in the observation group was more significant than that in the control group (P<0.05), while there was no significant difference between other values (P>0.05).

    Conclusion

    Shuxuetong can inhibit blood coagulation in the early stage of disease through the observing of TEG.

  • Article
  • Yunchao HUANG , Kelu YING , Anshu CHEN , Hong JIANG , Ting WANG
    doi: 10.13683/j.wph.2022.10.020
    Objective

    To explore changes of the main pulmonary artery diameter (dPA) and the ratio of main pulmonary artery to ascending aorta diameter (rPA) in patients with obstructive sleep apnea hypopnea syndrome (OSAHS), and to investigate the relationship between the changes of dPA and rPA with the apnea hypopnea index (AHI) and nocturnal minimum oxygen saturation (SpO2) in OSAHS patients without pulmonary hypertension by echocardiography.

    Methods

    A total of 146 patients with sleep respiration monitored in the Respiratory and Sleep Center of Zhongshan Hospital affiliated to Fudan University from 2019 to 2021 were retrospectively analyzed. All subjects underwent chest CT examination and heart ultrasound examination. According to the sleep apnea monitoring of sleep AHI and the lowest SpO2 group, dPA was measured and rPA was calculated under chest CT. The data of each group was collected and statistically analyzed.

    Results

    The dPA of patients with severe OSAHS was (2.82±0.33) cm, which was wider than that of patients with simple snoring (2.59±0.38) cm. The dPA of the severe SpO2 reduction group was (2.73±0.34) cm, and that of the mild SpO2 reduction group was (2.75±0.35) cm, which was wider than that of the normal SpO2 group (2.53±0.37) cm. At the same time, there was a positive correlation between AHI and dPA.

    Conclusion

    When pulmonary hypertension failed to detect by color doppler echocardiography in patients with OSAHS at the early stage of the disease, dPA measured by CT showed pulmonary artery widening in patients with OSAHS, which was positively correlated with AHI. Pulmonary artery width may have certain clinical significance for the early recognition of pulmonary hypertension and assessment of pulmonary artery pressure in patients with OSAHS.

  • Article
  • Renjun BAO , Xuanfu XU , Wenhui MO
    doi: 10.13683/j.wph.2022.10.021
    Objective

    To investigate the susceptible factors of liver injury after chemotherapy with R-CHOP (rituximab+cyclophosphamide+doxorubicin hydrochloride liposome injection+oncovin+prednisone) in non-Hodgkin lymphoma (NHL) patients, and to observe the hepatoprotective effect of prophylactic magnesium isocyanate.

    Methods

    The clinical data of 328 NHL patients who met the diagnostic criteria were collected and analyzed from January 1, 2016 to December 31, 2021 in the Department of Hematology, Shidong Hospital, Yangpu District, Shanghai. According to whether hepatoprotective treatment was used in chemotherapy, the patients were divided into two groups according to whether or not hepatoprotective treatment. First, the liver injury patients were determined in the group of unprotected liver patients, and the susceptible factors for liver injury after R-CHOP chemotherapy were analyzed. Then all patients were divided into four groups: non-susceptible factors without liver protection group (A group), susceptible factors without liver protection group (B group), non-susceptible factors with liver protection group (C group), susceptible factor with liver protection group (D group). Groups C and D were treated with magnesium isoglycyrrhizinate for liver protection. The incidence of liver injury and the changes of liver function indexes alanine aminotransferase (ALT), alkaline phosphatase (ALP) and (total bilirubin, TBiL)] of all patients before and after chemotherapy were compared and statistically analyzed.

    Results

    Alcohol consumption, non-alcoholic fatty liver disease, HBV carriers, and lymphoma liver infiltration were found to be independent susceptible factors for liver injury in NHL patients after R-CHOP chemotherapy. There was no significant difference in the incidence of liver injury (8.13%/5.48%) among the patients without susceptibility factors, while in the patients with susceptibility factors, the incidence of liver injury in the liver protection patients was significantly reduced (7.55%/40.51%). The levels of ALT, ALP and TBiL in patients with susceptibility factors were higher than those without susceptibility factors, and the differences were statistically significant (P<0.05).

    Conclusion

    Alcohol consumption, non-alcoholic fatty liver disease, HBV carriers and liver infiltration of lymphoma are independent susceptible factors for liver injury in NHL patients after R-CHOP chemotherapy. For NHL patients with the above susceptible factors, magnesium isoglycyrrhizinate can be used to protect the liver effectively during R-CHOP chemotherapy.

  • Review
  • Gang ZHENG , Xiongguan WANG , Xin LI , Qianqian XIE
    doi: 10.13683/j.wph.2022.10.022

    Vertigo and sudden deafness are common in clinic and have great impact on patients' life. Pentoxifylline is a non selective phosphodiesterase inhibitor, which can increase cyclic adenosine monophosphate in vertebral basilar artery and inner ear circulation cells, inhibit atherosclerosis and inflammation and improve hemorheology. Pentoxifylline may be used to treat vertigo and sudden deafness. This article reviewed the relevant research progress in order to provide reference for clinical practice.

  • Pharmacy administration
  • Xueying ZHANG , Guomei SHEN , Wei JIANG , Chunmei LIU , Hui CHEN , Xiaowen ZHAI
    doi: 10.13683/j.wph.2022.10.023
    Objective

    To investigate the use of antimicrobial agents and its influencing factors among parents of pediatric children, so as to provide evidence for better education on rational use of antibiotics.

    Methods

    A self-designed questionnaire was used to investigate the demographic characteristics of the parents of the children and the specific antimicrobial agents use behavior before, during and after the visit. Chi-square test was used for univariate analysis to determine the demographic factors of irrational antimicrobial agents use. Logistic regression analysis was used for multivariate analysis to determine how demographic factors affect the use of antibiotics.

    Results

    Before treatment, 20.8% of the parents had irrational antimicrobial agents use behavior, and the decision makers of antimicrobial agents use were the influencing factors of antimicrobial use behavior. The parents with irrational drug use behaviors accounted for 11.2%, and the family monthly income was the influencing factor of the parents' antimicrobial drug use behaviors. After treatment, 19.2% of the parents had irrational drug use. Medical insurance and reimbursement of outpatient expenses were the influencing factors of parents' antimicrobial agents use behavior.

    Conclusion

    The hospital is the main place for children's families to obtain the knowledge of antibacterial drugs. Therefore, it is very important for doctors to strengthen the propaganda and education of key contents such as abuse, random drug withdrawal, drug reduction and preparation of drugs for key groups during their visits, and to strengthen the propaganda and education of the relationship between diseases and antibacterial drugs, the hazards of abuse of antibacterial drugs, precautions for the use of antibacterial drugs, and antimicrobial drug resistance.

News